Register for our free email digests:
Division of Impax Laboratories Inc.
Latest From Zeneca Group PLC
Frank Armstrong is an industry veteran with no intention of slowing down. Over his 30-year career, he has held CEO roles with five biotechnology companies and led medical science and innovation at Merck Serono, and was previously executive vice president of product development at Bayer and senior vice president of medical research and communications at Zeneca. He now chairs the Finnish pharma company Faron's board and has high hopes for its drug Traumakine.
Sweden may link its existing value-based pricing system with international reference pricing to cut drug expenditure, a move the pharmaceuticals industry says would devastate domestic R&D there.
- Controlled Release
- Specialty Pharmaceuticals
- Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Impax Laboratories Inc.
- Senior Management
Michael Nestor, Pres.
Suneel Gupta, PhD, CSO
Shawn Fatholahi, VP, Sales & Mktg.
David Paterson, PhD, VP, Bus. Dev.
- Contact Info
Phone: (510) 240-6000
31047 Genstar Rd.
Hayward, CA 94544
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.